Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treatment of muscular dystrophy with ALK4:ActRIIB heteromultimers

Methods of treatment of muscular dystrophy with ALK4:ActRIIB heteromultimers

US Patent 12054753 · Granted Aug 6, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for producing levulinic acid2025
Cache circuit that selectively stores data blocks to dynamically optimize for re2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
TGF-beta superfamily type I and type II receptor heteromultimers and uses thereo2025
Cancer therapy involving an anti-PD1 antibody and a multi-specific binding prote2025
Multi-specific binding proteins that bind BCMA, NKG2D and CD16, and methods of u2025
Proteins binding NKG2D, CD16 and a tumor-associated antigen2025
Methods for treating heterotopic ossification2025
ALK7 binding proteins and uses thereof2025
ALK7 binding proteins and uses thereof2025